Table 1.
Present study | Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
---|---|---|---|---|---|
Study | – | Manivel et al. (13) | Sherbotie et al. (14) | Sherbotie et al. (14) | Alge et al. (15) |
Age at onset | 2 years | 26 months | 13 months | 16 months | 8 months |
Karyotype | 46, XY | 46, XY | 46, XY | 46, XY | 46, XX |
Morphological sex | Female | – | Male | Male | Female |
Initial manifestation | Rashes, abdominal pain, non-bloody loose stools, edema, anuria | HUS | UTI, edema | Edema, vomiting, decreased urine output | Oliguria, hypertension, vomiting |
Genital abnormality | Female external genitalia | Ambiguous external genitalia, bilateral Mullerian and right Wolffian | Grade III hypospadias with undescended testes | Grade III hypospadias with bifid scrotum, undescended testes | Absence of ovary |
Nephrotic syndrome | No | – | A month before HUS | At presentation with HUS | No |
DDS diagnosed before HUS | No | No | No | No | No |
C3 level | Normal | – | Normal | Normal | Decreased |
Renal pathology | Gross specimens: DMS and glomerular dysplasia | Initial biopsy: MPGN Gross specimens: DMS and metanephric hamartoma |
DMS without microangiopathic glomerulopathy | DMS without microangiopathic glomerulopathy | Initial biopsy: 3/8 glomeruli with globally sclerotic and the rest with active TMA Gross specimens: DMS |
Wilm's tumor | No | No | No | No | No |
Treatment | Plasma exchange | – | Plasmapheresis | – | Plasma infusions/exchange, eculizumab |
Renal function | Irreversible | Irreversible | Irreversible | Irreversible | Irreversible |
Outcome | Bilateral nephrectomy and renal transplantation at 3 years old, 10 months no recurrence | Bilateral nephrectomy, gonadectomy, and renal transplantation at 32 months old | PD; bilateral nephrectomy and renal transplantation at 2.5 years old, 4.5 years no recurrence | PD and HD; renal transplantation at 5 years old, 18 months no recurrence | PD; bilateral nephrectomy at 13 months old |
Complement abnormality | Not found | – | – | – | Autoantibody (-) CFH H3 haplotype with three SNPsa |
WT1 variation | Heterozygous, p. Asp252Asn in exon 9 |
– | Heterozygous, IVS9+111 C>T |
Heterozygous, p. Arg394Trp in exon 9 |
Heterozygous, p. Arg394Trp in exon 9 |
Clinvar interpretation | Pathogenic | – | Variant not in clinvar | Pathogenic | Pathogenic |
HUS, hemolytic uremic syndrome; DMS, diffuse mesangial sclerosis; UTI, urinary tract infection; SNPs, single-nucleotide polymorphisms; MPGN, membranoproliferative glomerulonephritis; PD, peritoneal dialysis; HD, hemodialysis.
c.1-332 C>T in the promoter, silent mutation at p. Gln672, and p. Glu936Asp substitution.